Seffalair Spiromax 55/14 mcg
Seffalair Spiromax 55/14 mcg is a medicine authorised by Swissmedic under authorisation number 67891. The authorisation holder is Teva Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 April 2021 and the authorisation is valid without a time limit. ATC code R03AK06 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 67891 |
|---|---|
| Name | Seffalair Spiromax 55/14 mcg |
| Full name | Seffalair Spiromax 55/14 mcg, Multidosenpulverinhalator |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03AK06 |
| First authorisation | 12 April 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Seffalair Spiromax 55/14 mcg, Multidosenpulverinhalator | B | 12 April 2021 |
| 2 | Seffalair Spiromax 113/14 mcg, Multidosenpulverinhalator | B | 12 April 2021 |
| 3 | Seffalair Spiromax 232/14 mcg, Multidosenpulverinhalator | B | 12 April 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Stück | R03AK06 | 03.04.3. | B |
| 2 | 60 | Stück | R03AK06 | 03.04.3. | B |
| 3 | 60 | Stück | R03AK06 | 03.04.3. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Seffalair Spiromax 55/14 mcg authorised in Switzerland?
Yes. Seffalair Spiromax 55/14 mcg is authorised by Swissmedic under authorisation number 67891, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Seffalair Spiromax 55/14 mcg have?
Seffalair Spiromax 55/14 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Seffalair Spiromax 55/14 mcg?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.